888209

Jubilant Cadista Pharmaceuticals — FEI 3017221809

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 8, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Yardley, PA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)